-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
GT Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- GT Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $196K, a 88% decline year-over-year.
- GT Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.93M, a 64.2% decline year-over-year.
- GT Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was $5.98M, a 1503% increase from 2022.
- GT Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was $373K.
- GT Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$498K, a 97.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)